Kaplitt M, Leopold P, Noch E, Ivanidze J, Chazen L, Crystal R, Kaminsky S, Bowe H, Wang M, Ballon D, Dyke J, Sondhi D, Gandy S, Giannantoni-Ibelli G, Barth JA. A Phase 1, Open-Label, 52-Week, Multicenter Study to Evaluate the Safety and Biochemical Efficacy of AAV Gene Therapy (LX1001) in Patients with APOE4 Homozygote Alzheimer’s Disease. Interim Data. JPAD 2022; 9(1): S33. JPAD CTAD Abstracts
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.